Advertisement

Topics

Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina

2014-09-24 15:14:26 | BioPortfolio

Published on BioPortfolio: 2014-09-24T15:14:26-0400

Clinical Trials [215 Associated Clinical Trials listed on BioPortfolio]

Statin Therapy In Patients With Vasospastic Angina

The purpose of this study is to evaluate whether statin is effective in the treatment of vasospastic angina.

Efficacy Study of Atorvastatin to Treat Variant Angina

The objective of this study is to evaluate effect of statin treatment for vasospastic angina.

Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness

Cilostazol is an antiplatelet agent used to reduce the symptoms of intermittent claudication. Cilostazol inhibits phosphodiesterase III (PDE III), which causes it to be a vasodilator and i...

Noninvasive Cardiac Imaging in Vasospastic Angina Korean Registry (NAVIGATOR)

With regard to the characteristics of spasm segment, had been clearly described by other invasive imaging methods including intravascular ultrasound and optical coherence tomography. Howev...

Cilostazol After Lower Extremity Arterial Revascularization Trial

Ten patients will be recruited to CLEAR. Five will be randomized to the treatment arm (Cilostazol) and five will be randomized to the control group. Patients randomized to the treatment ar...

PubMed Articles [108 Associated PubMed Articles listed on BioPortfolio]

Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers.

Previous studies indicate that sumatriptan is not effective when second messenger levels are high as after cilostazol provocation. Therefore, we have conducted the present study, where sumatriptan is ...

Ranolazine for Symptomatic Management of Microvascular Angina.

Ranolazine is approved in the United States and Europe for chronic stable angina. Microvascular angina (MVA) is defined as angina with no obstructive coronary artery disease.

Cilostazol for treatment of cerebral infarction.

Stroke not only causes critical disability and death but is also a cause of anxiety with the possibility of secondary cardiovascular events including secondary ischemic stroke. Indeed, patients with a...

Association of platelet response to cilostazol with clinical outcome and CYP genotype in patients with cerebral infarction.

Cilostazol, an anti-platelet drug that inhibits phosphodiesterase 3, is beneficial for patients with atherothrombosis. In contrast to other anti-platelet drugs such as aspirin and thienopyridines, lit...

Systemic microvascular dysfunction in microvascular and vasospastic angina.

Coronary microvascular dysfunction and/or vasospasm are potential causes of ischaemia in patients with no obstructive coronary artery disease (INOCA). We tested the hypothesis that these patients also...

Medical and Biotech [MESH] Definitions

ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes & Eponymic Diseases, 2d ed). It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.

A vasodilator used in angina of effort or ischemic heart disease.

Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.

2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.

A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.

More From BioPortfolio on "Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial